Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition
IAC Home
|
Vaccine Information Statements
|
Language Index
|
Chinese VISs

Vaccine Information Statements

Chinese-language VISs

Up-to-date translations

You are encouraged to distribute the current English version at the same time as the translation.
DTaP VIS
|
Current English version
Hib VIS
|
Current English version
Hepatitis A VIS
|
Current English version
HPV (Cervarix) VIS
|
Current English version
Influenza - inactivated (TIV) VIS
|
Current English version
Influenza - live intranasal (LAIV) VIS
|
Current English version
Meningococcal VIS
|
Current English version
MMRV VIS
|
Current English version
PCV13 VIS
|
Current English version
PPSV VIS
|
Current English version
Rotavirus VIS
|
Current English version
Shingles VIS
|
Current English version
Yellow fever VIS
|
Current English version
Chinese VIS
Adobe Reader®
|
PDF Help
Chinese-language Handouts
 

Out-of-date translations

The translations for some VISs on our website are from previously published English-language versions that have since been updated. Unfortunately, IAC is not always able to obtain translations as updates are issued. Please ensure that your patients receive information consistent with the current of the following VISs.
CHINESE TRANSLATION OF THE JANUARY 10, 2007 CHICKENPOX VIS
Chickenpox VIS
|
Current English version
This translation does not contain the following CDC updates:
spacer
Information was added about MMRV vaccine, tied to the March 14 MMWR, regarding increased risk of certain adverse events, including febrile seizures, with MMRV when compared with MMR and varicella vaccines given separately. Aside from two boxes containing information about MMRV, both VISs are identical to the previous editions.
spacer
The new VISs should be used when MMRV is given; but the existing stocks of the individual MMR and varicella VISs may be used when the vaccines are given separately.
CHINESE TRANSLATION OF THE JULY 11, 2001 HEPATITIS B VIS
Hepatitis B VIS
|
Current English version
This translation does not contain the following CDC updates:
spacer
On July 18, the CDC posted an interim VIS for hepatitis B. There are minor changes throughout, but the main purpose of the update is to emphasize the birth dose for all children.
spacer
A final version will be developed.
CHINESE TRANSLATION OF THE FEBRUARY 2, 2007 HPV VIS
HPV VIS
|
Current English version
This translation does not contain the following CDC updates:
spacer
Two VISs, one for Gardasil and one for Cervarix (both dated 3/30/2010), replace the single HPV VIS dated 2/2/07
spacer
Includes information about the use of Gardasil in males
CHINESE TRANSLATION OF THE MARCH 1, 2010 JAPANESE ENCEPHALITIS VIS
Japanese encephalitis VIS
|
Current English version
This translation does not contain the following CDC update:
spacer
The updated VIS reflects the fact that Ixiaro is now the only available vaccine for Japanese encephalitis. Minor changes concern patients younger than 17 (who can no longer be advised to get JE-VAX) and recommendations for booster doses. See the Note to Providers (also accessible from the main VIS page) for more information on these topics. Existing stocks of the previous (3/1/10) Ixiaro VIS may still be used, although it refers to JE-VAX as still being available.
CHINESE TRANSLATION OF THE JANUARY 15, 2003 MMR VIS
MMR VIS
|
Current English version
This translation does not contain the following CDC updates
spacer
Information was added about MMRV vaccine, tied to the March 14 MMWR, regarding increased risk of certain adverse events, including febrile seizures, with MMRV when compared with MMR and varicella vaccines given separately. Aside from two boxes containing information about MMRV, both VISs are identical to the previous editions.
spacer
The new VISs should be used when MMRV is given; but the existing stocks of the individual MMR and varicella VISs may be used when the vaccines are given separately.
CHINESE TRANSLATION OF THE JANUARY 30, 2008 MULTI-VACCINE VIS
Multi-vaccine VIS
|
Current English version
This translation does not contain the following CDC update:
spacer
IMulti-vaccine VIS update. An updated interim edition of the pediatric multi-vaccine VIS, dated September 18, 2008, has been posted. It has been made consistent with the recently updated rotavirus VIS by noting the availability of two rotavirus vaccines in the "Routine Childhood Vaccines" section and adding "irritability" to the mild problems listed for rotavirus in the "Vaccine Risks" section. Otherwise, the VIS is identical to the 1/30/08 edition. Providers using the multi-vaccine VIS when administering Rotarix should begin using the new edition now. When Rotarix is not administered, the older edition may be used until stocks are used up. (9/18/08)
CHINESE TRANSLATION OF THE SEPTEMBER 30, 2002 PCV7 VIS
PCV7 VIS
|
Current English version
This translation does not contain the following CDC update:
spacer
The CDC posted an updated interim PCV VIS on 12/9/08. The main reason is to incorporate recent changes in recommendations for 2-4 year olds, but there are other changes throughout as well. There are no changes in contraindications or adverse events, but to prevent parents from getting confused about the differences in indications (especially when the vaccine is administered to 2-4 year olds) it would be best for providers to start using the new version right away. Existing stocks CAN still be used temporarily if immediately switching to the new version is a problem.
CHINESE TRANSLATION OF THE JANUARY 1, 2000 POLIO - IPV VIS
Polio - IPV VIS
|
Current English version
This translation does not contain the following CDC update:
spacer
This edition does not differ significantly from the previous edition, particularly with regard to contraindications and adverse events. CDC encourages use of a new VIS upon publication; however, existing stocks of the previous edition may be used up.
CHINESE TRANSLATION OF THE NOVEMBER 18, 2008 TD/TDAP VIS
Td-Tdap VIS
|
Current English version
This translation does not contain the following CDC updates:
spacer
There are minor wording changes throughout, and a conversion to the new VIS format. The main reason for the change is to incorporate updated ACIP recommendations regarding children 7 through 9 years of age, adults 65 and older, and pregnant women; and to add a paragraph about the risk of syncope. Because of this addition to the "risks" section, CDC encourages providers to begin using the updated edition as soon as possible.
Thanks to the California Department of Health Services and the San Francisco Department of Public Health for their translations.
LANGUAGE INDEX
English Hindi Romanian
Amharic Hmong Russian
Arabic Ilokano Samoan
Armenian Indonesian Serbian
Bengali Italian Somali
Bosnian Japanese Spanish
Burmese Karen Tagalog
Cambodian Korean Thai
Chinese Laotian Turkish
Croatian Marshallese Urdu
Farsi Nepali Vietnamese
French Polish Yiddish
German Portuguese  
Haitian Creole Punjabi  
VIS VACCINE INDEX
 
How to use VISs
It's Federal Law! You must give your patients current VISs
Explains why it is necessary to always use the most current version of a VIS and lists the current VIS dates
 
Related materials from IAC
Ask the Experts
Handouts
IAC Express
Needle Tips
Vaccinate Adults
Vaccine Policy & Licensing
What's New at IAC
 
GLT
GRT
 
Language Locator
Use this table to find which non-English VIS can help you serve patients from a given country.
alt
LEARN MORE
 
GLB
GRB
 
GLT
GRT
 
Translate for IAC
If you have a need for a VIS in a language that is not currently offered, please consider translating for IAC yourself and then sharing it with the world via this website!
LEARN MORE
 
GLB
GRB
 
GLT
GRT
 
More from IAC
envelope Subscribe to IAC
Periodicals and email news service - all free!
dollar sign Support IAC
Your support can make a difference!
shopping cart Shop IAC
DVDs, schedules, record cards, and more!
 
GLB
GRB
This page was reviewed on February 6, 2012
Immunization Action Coalition  •  1573 Selby Ave  •  St. Paul, MN 55104
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.